ScholarLens Back to search
2023•Unpublished venueOpen access

Supplementary Figure S2 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study

Joel R. Eisner, Gregory M. Mayhew, James M. Davison, Kirk D. Beebe, Yoichiro Shibata, Yuelong Guo, Carol Farhangfar, Farhang Farhangfar, Joshua M. Uronis, Jeffrey M. Conroy, Michael V. Milburn, D. Neil Hayes, Kathryn F. Mileham

Open full text 0 citations

Abstract

Expression of Genes Associated with Antifolate (Pemetrexed) Activity by LUAD Subtype.

About this research paper

What this paper is about

Expression of Genes Associated with Antifolate (Pemetrexed) Activity by LUAD Subtype.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Expression of Genes Associated with Antifolate (Pemetrexed) Activity by LUAD Subtype.

Key concepts: Pemetrexed, Antifolate, Lung cancer, Chemotherapy, Oncology, Medicine, Internal medicine, Adenocarcinoma

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Supplementary Figure S2 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study — Research Paper | ScholarLens